Companies
The Pharma Industry's Most Promising Drug Candidates
January 2007 | Company Finance AlertThe Scientific American journal has released a list of the most promising drugs that have completed phase 1 trials. The majority of the treatments concern therapeutic areas associated with ageing such as arthritis and dementia, as well as 'diseases of civilisation' like obesity and diabetes. Cancer is also well represented, as it remains the leading killer in the West.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
